{"transactions":[{"id":3319047,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:29:03.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":8410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":34.81,"underlying":"Common Stock","underlying_shares":8410},"source":{"system":"sec-edgar","filing":"0000950142-20-000046","document":"es2000131_4-panayiotopoulos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000046/es2000131_4-panayiotopoulos.xml","form_type":"4"}},{"id":3319046,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:29:03.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":9141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":33.86,"underlying":"Common Stock","underlying_shares":9141},"source":{"system":"sec-edgar","filing":"0000950142-20-000046","document":"es2000131_4-panayiotopoulos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000046/es2000131_4-panayiotopoulos.xml","form_type":"4"}},{"id":3319045,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:29:03.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":8577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":39.39,"underlying":"Common Stock","underlying_shares":8577},"source":{"system":"sec-edgar","filing":"0000950142-20-000046","document":"es2000131_4-panayiotopoulos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000046/es2000131_4-panayiotopoulos.xml","form_type":"4"}},{"id":3319044,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:29:03.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":16559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":51.02,"underlying":"Common Stock","underlying_shares":16559},"source":{"system":"sec-edgar","filing":"0000950142-20-000046","document":"es2000131_4-panayiotopoulos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000046/es2000131_4-panayiotopoulos.xml","form_type":"4"}},{"id":3319043,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T13:29:03.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":13881,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of November 23, 2019 (the \"Merger Agreement\"), by and among the Company, Novartis AG (\"Parent\") and Medusa Merger Corporation (\"Purchaser\"), on January 6, 2020, Purchaser was merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as an indirect wholly-owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company (each a \"Share\") was converted into the right to receive $85.00 per Share, net to the seller in cash (the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of Shares reported includes 3,663 unvested restricted Shares (each a \"Restricted Share\"). Each Restricted Share that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser automatically became fully vested as of immediately prior to, and contingent upon, the effective time of the Merger and was treated in the same manner as an outstanding Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-20-000046","document":"es2000131_4-panayiotopoulos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000046/es2000131_4-panayiotopoulos.xml","form_type":"4"}},{"id":3475842,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2019-06-28T20:06:36.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":33300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":33300,"derivative":{"exercise_price":7.31,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":33300},"source":{"system":"sec-edgar","filing":"0001209191-19-039469","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119039469/doc4.xml","form_type":"4"}},{"id":3505108,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2019-06-03T17:13:27.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":8410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in one installment on May 30, 2020 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":8410,"derivative":{"exercise_price":34.81,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":8410},"source":{"system":"sec-edgar","filing":"0001179110-19-007028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911019007028/edgar.xml","form_type":"4"}},{"id":3505107,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-03T17:13:27.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":3663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests on May 30, 2020 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":13881,"source":{"system":"sec-edgar","filing":"0001179110-19-007028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911019007028/edgar.xml","form_type":"4"}},{"id":3908851,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2018-06-04T16:53:15.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":9141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in one installment on May 31, 2019 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":9141,"derivative":{"exercise_price":33.86,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":9141},"source":{"system":"sec-edgar","filing":"0001179110-18-007956","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911018007956/edgar.xml","form_type":"4"}},{"id":3908850,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T16:53:15.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests on May 31, 2019 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":10218,"source":{"system":"sec-edgar","filing":"0001179110-18-007956","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911018007956/edgar.xml","form_type":"4"}},{"id":3915016,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2018-05-29T20:11:50.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":34000,"derivative":{"exercise_price":5.93,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-18-033781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919118033781/doc4.xml","form_type":"4"}},{"id":4146353,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-01T17:47:58.000Z","date":"2017-11-30","kind":"purchase","acquired":true,"shares":3215,"price":30.97,"value":99568.55,"ownership":{"direct":true},"balance_after":6452,"source":{"system":"sec-edgar","filing":"0001179110-17-014789","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014789/edgar.xml","form_type":"4"}},{"id":4157570,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T15:04:31.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":14285,"price":7.0278,"value":100392.123,"ownership":{"direct":true},"balance_after":14285,"source":{"system":"sec-edgar","filing":"0001209191-17-061358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117061358/doc4.xml","form_type":"4"}},{"id":4183489,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2017-10-18T11:50:50.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":61000,"derivative":{"exercise_price":6.9,"expiration_date":"2027-10-16","underlying":"Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001209191-17-057230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117057230/doc4.xml","form_type":"4"}},{"id":4301588,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2017-05-30T19:40:56.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in one installment on May 25, 2018 and is made as part of and pursuant to Issuer's director compensation package."}],"balance_after":8577,"derivative":{"exercise_price":39.39,"expiration_date":"2017-05-25","underlying":"Common Stock","underlying_shares":8577},"source":{"system":"sec-edgar","filing":"0001179110-17-008215","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017008215/edgar.xml","form_type":"4"}},{"id":4301587,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T19:40:56.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":3237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award vests on May 25, 2018 and is made as part of and pursuant to Issuer's director compensation package."}],"balance_after":3237,"source":{"system":"sec-edgar","filing":"0001179110-17-008215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017008215/edgar.xml","form_type":"4"}},{"id":4367131,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Call Option (right-to-buy)","published_at":"2017-03-31T14:42:01.000Z","date":"2017-03-28","kind":"grant","acquired":true,"shares":16559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in one installment on March 28, 2027 and is made part of and pursuant to Issuer's director compensation package."}],"balance_after":16559,"derivative":{"exercise_price":51.02,"expiration_date":"2027-03-28","underlying":"Common Stock","underlying_shares":16559},"source":{"system":"sec-edgar","filing":"0001179110-17-005296","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017005296/edgar.xml","form_type":"4"}},{"id":4443834,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-02-16T14:15:31.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":66800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a right to receive one Share. Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the Offer automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum cash payment in an amount equal to $24.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a right to receive one Share. Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the Offer automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum cash payment in an amount equal to $24.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":66800},"source":{"system":"sec-edgar","filing":"0000884731-17-000051","document":"wf-form4_148727251700389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000051/wf-form4_148727251700389.xml","form_type":"4"}},{"id":4443833,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-16T14:15:31.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."}],"balance_after":0,"derivative":{"exercise_price":5.34,"underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0000884731-17-000051","document":"wf-form4_148727251700389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000051/wf-form4_148727251700389.xml","form_type":"4"}},{"id":4443832,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-16T14:15:31.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":159378,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of January 8, 2017 (the \"Merger Agreement\"), between the Company, Takeda Pharmaceutical Company Limited (\"Takeda\") and Kiku Merger Co., Inc. (\"Purchaser\"), on February 16, 2017, Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive $24.00 in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000884731-17-000051","document":"wf-form4_148727251700389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000051/wf-form4_148727251700389.xml","form_type":"4"}},{"id":4490360,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-01-17T17:06:52.000Z","date":"2017-01-13","kind":"exercise","acquired":false,"shares":66600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU vests as to approximately one third of the award on each of July 13, 2016, January 13, 2017 and July 13, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"N/A"}],"balance_after":66800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":66600},"source":{"system":"sec-edgar","filing":"0000884731-17-000004","document":"wf-form4_148469079934747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000004/wf-form4_148469079934747.xml","form_type":"4"}},{"id":4490359,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-17T17:06:52.000Z","date":"2017-01-17","kind":"tax_withholding","acquired":false,"shares":33300,"price":23.6917,"value":788933.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold to satisfy withholding tax requirements pursuant to a Rule 10b5-1 trading plan adopted June 15, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $23.67 to $23.72, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer,or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote."}],"balance_after":159378,"source":{"system":"sec-edgar","filing":"0000884731-17-000004","document":"wf-form4_148469079934747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000004/wf-form4_148469079934747.xml","form_type":"4"}},{"id":4490358,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":152554,"kind":"person","name":"Panayiotopoulos Paris","position":1,"cik":"0001662996","reported_name":"Panayiotopoulos Paris","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-17T17:06:52.000Z","date":"2017-01-13","kind":"exercise","acquired":true,"shares":66600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon the vesting of a Restricted Stock Unit previously granted on January 13, 2016."}],"balance_after":192678,"source":{"system":"sec-edgar","filing":"0000884731-17-000004","document":"wf-form4_148469079934747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000004/wf-form4_148469079934747.xml","form_type":"4"}}]}